Publication:
Evaluation of <sup>1</sup>H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration

dc.contributor.authorBonnie N. Joeen_US
dc.contributor.authorVictoria Y. Chenen_US
dc.contributor.authorNouha Salibien_US
dc.contributor.authorPornpim Fuangtharntipen_US
dc.contributor.authorCharles F. Hildebolten_US
dc.contributor.authorKyongtae T. Baeen_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherSiemens USAen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherWashington University School of Medicine in St. Louis, Mallinckrodt Institute of Radiologyen_US
dc.date.accessioned2018-06-21T08:26:43Z
dc.date.available2018-06-21T08:26:43Z
dc.date.issued2005-07-01en_US
dc.description.abstractObjectives: We sought to evaluate spectroscopic measurements in breast cancer and compare variability in choline peak parameters related to contrast administration versus that inherent to repeated measurements. Materials and Methods: Single-voxel, proton spectroscopy measurements were obtained before and after the administration of gadolinium on 15 patients with ≥1-cm breast cancers. The protocol was repeated on a separate day in 7 patients. Results: Postcontrast spectra demonstrated a significant increase in choline peak linewidth (day 1: 15% ± 21%, P = 0.03; day 2: 19% ± 12%, P = 0.001) and decrease in choline peak area (day 1: 11% ± 9% (P < 0.001); day 2: 18% ± 21% (P = 0.03). A variance-components analysis indicated that day-to-day variation in linewidth accounted for 0.0% of the total variation in width measurements and was not significant (P = 0.85). Day-to-day variation in area was also not significant (0.0%, P = 0.95). Conclusions: Contrast administration caused significant increases in choline peak linewidth and decreases in choline peak area in spectroscopic measurements of breast cancer. Copyright © 2005 by Lippincott Williams & Wilkins.en_US
dc.identifier.citationInvestigative Radiology. Vol.40, No.7 (2005), 405-411en_US
dc.identifier.doi10.1097/01.rli.0000167125.79212.5den_US
dc.identifier.issn00209996en_US
dc.identifier.other2-s2.0-20844433248en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/16947
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=20844433248&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEvaluation of <sup>1</sup>H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administrationen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=20844433248&origin=inwarden_US

Files

Collections